PKR inhibitor (Protekt Therapeutics)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePKR inhibitor (Protekt Therapeutics)
Drug Alias Namedouble-stranded RNA-activated protein kinase inhibitor (Protekt Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterferon-induced, double-stranded RNA-activated protein kinase inhibitors
TargetsInterferon-induced, double-stranded RNA-activated protein kinase
Therapy Area/IndicationsCognitive Dysfunction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProtekt Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProtekt Therapeutics
Active IndicationsN/A
Inactive IndicationsCognitive Dysfunction

Other Information

ATC CodeN/A
Related LinksN/A